June 30, 2014

Upsher-Smith Labs announced the launch of Qudexy XR (topiramate) extended-release capsules, a once-a-day antiepileptic drug engineered to provide a smooth pharmacokinetic profile.

March 5, 2014

Upsher-Smith Labs introduced a new educational program created for patients living with seizure clusters, as well as their families and friends.

January 13, 2014

More than three-dozen pharmacists in 41 states will receive the 2013 National Alliance of State Pharmacy Associations' Excellence in Innovation Award, which is designed to recognize pharmacists who have demonstrated significant innovation in their practice.

December 9, 2013

An experimental drug under development by Upsher-Smith Labs for epilepsy is able to reduce seizures in patients with mild to moderate side effects, according to results of a late-stage clinical trial announced Monday.

November 18, 2013

Drug maker Upsher-Smith Labs will present data from a late-stage trial of a drug for treating epilepsy, the company said Monday.

September 3, 2013

A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.

June 6, 2013

A healthcare products distribution trade group has given drug maker Upsher-Smith Labs one of its top awards, Upsher-Smith said.

September 11, 2012

Drug maker Upsher-Smith Labs has introduced a new product to its prenatal vitamin line, the company said Tuesday.

August 14, 2012

Upsher-Smith Labs has finalized its purchase of a British company that makes drugs for central nervous system and inflammatory disorders, the former said Tuesday.

June 25, 2012

Upsher-Smith Labs has launched a probiotic dietary supplement specifically designed for women to promote digestive, feminine and immune health, the company said.

June 15, 2012

Upsher-Smith wins 2012 DIANAs in Branded Pharmaceutical Product Manufacturer and Consumer Product Manufacturer categories.

June 13, 2012

Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.

April 25, 2012

Drug maker Upsher-Smith Labs will unveil updates to its educational website for healthcare providers who specialize in epilepsy at the American Academy of Neurology's annual meeting in New Orleans, the company said.

January 24, 2012

Drug maker Upsher-Smith Labs has launched a prenatal vitamin designed to help relieve morning sickness, the company said Monday.

September 7, 2011

Upsher-Smith Labs, maker of the AmLactin family of moisturizers, has announced the launch of the AmLactin Facebook page.

July 18, 2011

Upsher-Smith Labs has started a late-stage clinical trial of a drug for treating patients with a rare and severe form of epilepsy, the drug maker said Monday.

July 11, 2011

Upsher-Smith Labs has launched a topical medication for itching and inflammation of the skin resulting from such conditions as psoriasis and atopic dermatitis, the company said Monday.

November 8, 2010

Drug maker Upsher-Smith Labs will add an extension study to its late-stage clinical trial of...